Member Info for Toukankahmoon

Thompi

But none of these give us any clue as to dox in the tumour and yes I know it was a safety trial which is what I’m trying to impress on the rampers.

Anyway hopefully with rich data reveal we will (soon) find out.

Watching

How can one find out who has removed one’s post. As a poster who seems to be affected by this more than others I would like to know.

Smeag + cj62

Ok I’ve rewatched the video. Nothing there precludes my concerns about excretion versus cleaving. It is great that safety profile allows more frequent dosing and better still that it keeps a higher concentration of AVA6000 in the blood for longer. Anyway we will see what is actually happening when arm 2 finishes whenever that is.

And my point about how the trial had to be extended being a surprise because the “results were far better than expected” still stands The rat trial results certainly predicted those results. And I can’t remember Avacta saying “better than expected “ I think they just said “unexpected “. But I am more than happy if someone finds that quote.

Finally I am invested and want it to work but I do take offence to the constant black and white “it works”.

Bein

AVA6000 safety is proven. Efficacy is not. It isn’t enough for it not to kill people. I think that there is a possibility that excretion rate exceeds cleaving rate for some patient characteristics hence 2 week dosing trial and stony silence on C7. IMO

Gje306

Why wouldn’t we believe the timelines? Some posters keep telling us that because of the changed design of the trails, we are ahead of the target to get onto the market.

It is fantastic that SP is back up to 54p though I wonder how high it needs to get before profit taking steps in though I would only expect that to cause a small dip before carrying on up to find a stable value.

ATBD

I don’t think that anyone on here is questioning the marvellous results (similar to rat trials) that Avacta have announced for 4 out of 40 patients. Neither the safety profile achieved. But 4 is not statistically significant.

Regarding AACR prepare to be disappointed. All the stuff you mentioned (which we desperately need to know) has not been promised by Avacta.

So stop ramping and wait

My point is that they would have to have a presence anyway but I’m not saying that there won’t be an excellent presentation. Just not very likely.

Bella

It’s one of the biggest annual industry shindigs they have to have a presence and chat to their mates. Keep up with the competition etc.

they would go if they had nothing to present

Because if it all goes twats up Tim has lost his pension pot.

Cj62

Why is it you feel the need to be insulting even when I’ve supported your original post? Do you get some perverted kicks out of it?

Cj62

Polite constructive post as usual.

Watching

as it happens I do have an extensive collection of die cast 1:43 cars and a great joy to me they are too

Yep 12 months is reasonable timescale. So hope all the tripe about mega deals next week can stop.

Icecool

You are slipping. You’ve never let facts get in the way of your wishful ramping before🤣

They should be ashamed. Don’t they know they are damaging Avacta’s prospects of getting life saving drugs to market?

Ronny

I have a clearly stated agenda and that is to debunk the totally unfounded wishful thinking tripe posted by the potty mouthed fantasists.

Just a meeting to pass the resolution.

Perhaps an RNS tomorrow to reveal the European investor?

Or will we now have to wait for AACR for the pivotal moment.

Yeah but where was the wonderful news?

JWB

No RNS tomorrow morning revealing European investor. £5 by the close.